Philips HeartStart Onsite (HS1) AED (Refurbished)
- Refurbished and BioMed Certified Philips HeartStart OnSite AED
- New Battery
- New Adult Pads Cartridge
- Carry Case
- 1 Certified BioMed Equipment Diagnostic Report
- 1 Year Warranty
Available without a prescription, the HeartStart OnSite Defibrillator is
designed with innovative technology, based on extensive research and user
feedback, that has produced a defibrillator so easy to set up and use that you
can potentially save the life of a co-worker, friend, or anyone else stricken
with sudden cardiac arrest.
Weighing just 3.3 lbs., this small and lightweight defibrillator can be easily
carried to the victims side.
Using clear, natural voice instructions, the HeartStart OnSite Defibrillator
guides you through each step of defibrillation. Designed to not slow you down or
leave you behind, it paces and adapts voice instructions to your actions every
step of the way. It even reminds you to call emergency medical services (EMS).
On-demand CPR Coaching helps the stressed user recall their training.
Every meticulously built HeartStart OnSite Defibrillator goes
through a 120 point test before it leaves the factory. On the job, the OnSite
automatically conducts self-tests every single day, not just weekly. It performs
over 80 different tests in all. Even the pads are tested for readiness.
Philips pioneered the use of biphasic waveforms in external
defibrillators. The electric medicine delivered by the HeartStart OnSite has
been rigorously studied, with more than 40 studies demonstrating high first
shock efficacy and effectiveness across the full spectrum of patients. Philips
SMART Biphasic therapy uses a unique combination of high current to maximize
effectiveness and a lower energy dose to minimize side effects that are harmful
to a fragile heart. The result - the HeartStart OnSite delivers its maximum
shock strength starting with the first shock.
HeartStart OnSites Quick Shock feature delivers therapy in just 8 seconds
(typical) after chest compressions. Other devices can take 2 or 3 three times
that, reducing the likelihood of shock success, and potentially, survival.